Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation

Simon S. Yoo, Darryl Carter, Bruce C. Turner, Clarence T. Sasaki, Yung H. Son, Lynn D. Wilson, Peter M. Glazer, Bruce G. Haffty*

*Corresponding author for this work

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Recent laboratory experiments have demonstrated that cyclin D1 levels (cycD1) can influence radiosensitivity. The purpose of the current study is to evaluate the prognostic significance of cycD1 for local recurrence in early-stage larynx cancer treated with primary radiation therapy. The study was conducted using a matched case-control design in 60 early-stage (T1- T2/N0) larynx cancer patients. All patients had squamous cell carcinoma of the larynx and were treated with primary radiation to a total median dose of 66 Gy in daily fractions of 2 Gy, without surgery or chemotherapy. Thirty patients who suffered a local relapse in the larynx after treatment served as the index case population. These 30 cases were matched by age, sex, site (glottic vs. supraglottic), radiation therapy technique/dose, and follow-up, to 30 control patients who did not experience a local relapse. Immunohistochemical staining from cycD1 was performed on the paraffin- embedded specimens. The pathologist, blinded to the clinical information, scored each of the specimens on a four-point intensity scale (0 = no stain, 1 = faint, 2 = moderate, 3 = strong) and percent distribution. Patients were considered to be positive for cyclin D1 if the staining was 2+ or greater with a percent distribution of at least 5%. By design of the study, the two groups were evenly balanced with respect to age, sex, stage, radiation dose, and follow-up. CycD1 levels correlated with proliferating cell nuclear antigen levels. Low levels of cycD1 significantly correlated with local relapse; 19/30 (63%) of the index cases stained negative, while only 10/30 (33%) of the control cases stained negative (P = 0.03). These data suggest that low levels of cycD1 correlate with relatively radioresistant early-stage larynx carcinoma. With larger more confirmatory clinical and laboratory data, this data may have significant clinical implications. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)22-28
Number of pages7
JournalInternational Journal of Cancer
Volume90
Issue number1
DOIs
StatePublished - Feb 20 2000

Fingerprint

Laryngeal Neoplasms
Cyclin D1
Radiation
Larynx
Recurrence
Proteins
Radiotherapy
Staining and Labeling
Radiation Tolerance
Proliferating Cell Nuclear Antigen
Tongue
Paraffin
Squamous Cell Carcinoma
Coloring Agents
Carcinoma
Drug Therapy
Population

Keywords

  • Cyclin D1
  • Head and neck cancer
  • Larynx cancer
  • Proliferating cell nuclear antigen (PCNA)
  • Radiation sensitivity
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yoo, Simon S. ; Carter, Darryl ; Turner, Bruce C. ; Sasaki, Clarence T. ; Son, Yung H. ; Wilson, Lynn D. ; Glazer, Peter M. ; Haffty, Bruce G. / Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation. In: International Journal of Cancer. 2000 ; Vol. 90, No. 1. pp. 22-28.
@article{c534cd2db314488fba1e66043cb9c4ba,
title = "Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation",
abstract = "Recent laboratory experiments have demonstrated that cyclin D1 levels (cycD1) can influence radiosensitivity. The purpose of the current study is to evaluate the prognostic significance of cycD1 for local recurrence in early-stage larynx cancer treated with primary radiation therapy. The study was conducted using a matched case-control design in 60 early-stage (T1- T2/N0) larynx cancer patients. All patients had squamous cell carcinoma of the larynx and were treated with primary radiation to a total median dose of 66 Gy in daily fractions of 2 Gy, without surgery or chemotherapy. Thirty patients who suffered a local relapse in the larynx after treatment served as the index case population. These 30 cases were matched by age, sex, site (glottic vs. supraglottic), radiation therapy technique/dose, and follow-up, to 30 control patients who did not experience a local relapse. Immunohistochemical staining from cycD1 was performed on the paraffin- embedded specimens. The pathologist, blinded to the clinical information, scored each of the specimens on a four-point intensity scale (0 = no stain, 1 = faint, 2 = moderate, 3 = strong) and percent distribution. Patients were considered to be positive for cyclin D1 if the staining was 2+ or greater with a percent distribution of at least 5{\%}. By design of the study, the two groups were evenly balanced with respect to age, sex, stage, radiation dose, and follow-up. CycD1 levels correlated with proliferating cell nuclear antigen levels. Low levels of cycD1 significantly correlated with local relapse; 19/30 (63{\%}) of the index cases stained negative, while only 10/30 (33{\%}) of the control cases stained negative (P = 0.03). These data suggest that low levels of cycD1 correlate with relatively radioresistant early-stage larynx carcinoma. With larger more confirmatory clinical and laboratory data, this data may have significant clinical implications. (C) 2000 Wiley-Liss, Inc.",
keywords = "Cyclin D1, Head and neck cancer, Larynx cancer, Proliferating cell nuclear antigen (PCNA), Radiation sensitivity, Squamous cell carcinoma",
author = "Yoo, {Simon S.} and Darryl Carter and Turner, {Bruce C.} and Sasaki, {Clarence T.} and Son, {Yung H.} and Wilson, {Lynn D.} and Glazer, {Peter M.} and Haffty, {Bruce G.}",
year = "2000",
month = "2",
day = "20",
doi = "10.1002/(SICI)1097-0215(20000220)90:1<22::AID-IJC3>3.0.CO;2-T",
language = "English (US)",
volume = "90",
pages = "22--28",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation. / Yoo, Simon S.; Carter, Darryl; Turner, Bruce C.; Sasaki, Clarence T.; Son, Yung H.; Wilson, Lynn D.; Glazer, Peter M.; Haffty, Bruce G.

In: International Journal of Cancer, Vol. 90, No. 1, 20.02.2000, p. 22-28.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation

AU - Yoo, Simon S.

AU - Carter, Darryl

AU - Turner, Bruce C.

AU - Sasaki, Clarence T.

AU - Son, Yung H.

AU - Wilson, Lynn D.

AU - Glazer, Peter M.

AU - Haffty, Bruce G.

PY - 2000/2/20

Y1 - 2000/2/20

N2 - Recent laboratory experiments have demonstrated that cyclin D1 levels (cycD1) can influence radiosensitivity. The purpose of the current study is to evaluate the prognostic significance of cycD1 for local recurrence in early-stage larynx cancer treated with primary radiation therapy. The study was conducted using a matched case-control design in 60 early-stage (T1- T2/N0) larynx cancer patients. All patients had squamous cell carcinoma of the larynx and were treated with primary radiation to a total median dose of 66 Gy in daily fractions of 2 Gy, without surgery or chemotherapy. Thirty patients who suffered a local relapse in the larynx after treatment served as the index case population. These 30 cases were matched by age, sex, site (glottic vs. supraglottic), radiation therapy technique/dose, and follow-up, to 30 control patients who did not experience a local relapse. Immunohistochemical staining from cycD1 was performed on the paraffin- embedded specimens. The pathologist, blinded to the clinical information, scored each of the specimens on a four-point intensity scale (0 = no stain, 1 = faint, 2 = moderate, 3 = strong) and percent distribution. Patients were considered to be positive for cyclin D1 if the staining was 2+ or greater with a percent distribution of at least 5%. By design of the study, the two groups were evenly balanced with respect to age, sex, stage, radiation dose, and follow-up. CycD1 levels correlated with proliferating cell nuclear antigen levels. Low levels of cycD1 significantly correlated with local relapse; 19/30 (63%) of the index cases stained negative, while only 10/30 (33%) of the control cases stained negative (P = 0.03). These data suggest that low levels of cycD1 correlate with relatively radioresistant early-stage larynx carcinoma. With larger more confirmatory clinical and laboratory data, this data may have significant clinical implications. (C) 2000 Wiley-Liss, Inc.

AB - Recent laboratory experiments have demonstrated that cyclin D1 levels (cycD1) can influence radiosensitivity. The purpose of the current study is to evaluate the prognostic significance of cycD1 for local recurrence in early-stage larynx cancer treated with primary radiation therapy. The study was conducted using a matched case-control design in 60 early-stage (T1- T2/N0) larynx cancer patients. All patients had squamous cell carcinoma of the larynx and were treated with primary radiation to a total median dose of 66 Gy in daily fractions of 2 Gy, without surgery or chemotherapy. Thirty patients who suffered a local relapse in the larynx after treatment served as the index case population. These 30 cases were matched by age, sex, site (glottic vs. supraglottic), radiation therapy technique/dose, and follow-up, to 30 control patients who did not experience a local relapse. Immunohistochemical staining from cycD1 was performed on the paraffin- embedded specimens. The pathologist, blinded to the clinical information, scored each of the specimens on a four-point intensity scale (0 = no stain, 1 = faint, 2 = moderate, 3 = strong) and percent distribution. Patients were considered to be positive for cyclin D1 if the staining was 2+ or greater with a percent distribution of at least 5%. By design of the study, the two groups were evenly balanced with respect to age, sex, stage, radiation dose, and follow-up. CycD1 levels correlated with proliferating cell nuclear antigen levels. Low levels of cycD1 significantly correlated with local relapse; 19/30 (63%) of the index cases stained negative, while only 10/30 (33%) of the control cases stained negative (P = 0.03). These data suggest that low levels of cycD1 correlate with relatively radioresistant early-stage larynx carcinoma. With larger more confirmatory clinical and laboratory data, this data may have significant clinical implications. (C) 2000 Wiley-Liss, Inc.

KW - Cyclin D1

KW - Head and neck cancer

KW - Larynx cancer

KW - Proliferating cell nuclear antigen (PCNA)

KW - Radiation sensitivity

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0034688661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034688661&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(20000220)90:1<22::AID-IJC3>3.0.CO;2-T

DO - 10.1002/(SICI)1097-0215(20000220)90:1<22::AID-IJC3>3.0.CO;2-T

M3 - Article

VL - 90

SP - 22

EP - 28

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -